Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Tonon

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|June 5, 2010
TFM-Explorer: mining cis-regulatory regions in genomesLaurie Tonon, Hélène Touzet, Jean-Stéphane Varré
Bulletin Du Cancer|January 1, 2019
Stéphane Depil, Paola Bonaventura, Vincent Alcazer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Neoepitopes-based vaccines: challenges and perspectivesVincent Alcazer, Paola Bonaventura, Laurie Tonon, et al.
Nucleic Acids Research|November 4, 2015
Norine, the knowledgebase dedicated to non-ribosomal peptides, is now open to crowdsourcingAreski Flissi, Yoann Dufresne, Juraj Michalik, et al.
Cancer Cell International|February 3, 2025
EMT-driven plasticity prospectively increases cell-cell variability to promote therapeutic adaptation in breast cancerLauriane Muller, Frédérique Fauvet, Christelle Chassot, et al.
EMBO Reports|February 21, 2023
Pericyte stem cells induce Ly6G<sup>+</sup> cell accumulation and immunotherapy resistance in pancreatic cancerZhichong Wu, Kevin Thierry, Sophie Bachy, et al.
Science Advances|February 14, 2024
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticityHadrien De Blander, Laurie Tonon, Frédérique Fauvet, et al.
Nature Communications|July 11, 2020
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolutionRoxane M Pommier, Amélien Sanlaville, Laurie Tonon, et al.
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Nature Communications|July 3, 2025
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency featuresValentin Picant, Lara Revol-Bauz, Laurie Tonon, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|June 5, 2010
TFM-Explorer: mining cis-regulatory regions in genomesLaurie Tonon, Hélène Touzet, Jean-Stéphane Varré
Bulletin Du Cancer|January 1, 2019
Stéphane Depil, Paola Bonaventura, Vincent Alcazer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Neoepitopes-based vaccines: challenges and perspectivesVincent Alcazer, Paola Bonaventura, Laurie Tonon, et al.
Nucleic Acids Research|November 4, 2015
Norine, the knowledgebase dedicated to non-ribosomal peptides, is now open to crowdsourcingAreski Flissi, Yoann Dufresne, Juraj Michalik, et al.
Cancer Cell International|February 3, 2025
EMT-driven plasticity prospectively increases cell-cell variability to promote therapeutic adaptation in breast cancerLauriane Muller, Frédérique Fauvet, Christelle Chassot, et al.
EMBO Reports|February 21, 2023
Pericyte stem cells induce Ly6G<sup>+</sup> cell accumulation and immunotherapy resistance in pancreatic cancerZhichong Wu, Kevin Thierry, Sophie Bachy, et al.
Science Advances|February 14, 2024
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticityHadrien De Blander, Laurie Tonon, Frédérique Fauvet, et al.
Nature Communications|July 11, 2020
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolutionRoxane M Pommier, Amélien Sanlaville, Laurie Tonon, et al.
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Nature Communications|July 3, 2025
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency featuresValentin Picant, Lara Revol-Bauz, Laurie Tonon, et al.
Pageof 4